X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1015) 1015
humans (940) 940
male (462) 462
female (457) 457
infectious diseases (380) 380
anti-bacterial agents - therapeutic use (372) 372
middle aged (331) 331
intraabdominal infections (319) 319
pharmacology & pharmacy (312) 312
microbiology (305) 305
surgery (303) 303
adult (289) 289
aged (288) 288
intraabdominal infections - drug therapy (220) 220
antibiotics (210) 210
treatment outcome (201) 201
complicated intraabdominal infections (187) 187
microbial sensitivity tests (177) 177
bacterial infections - drug therapy (166) 166
management (162) 162
anti-bacterial agents - pharmacology (161) 161
intraabdominal infections - microbiology (147) 147
mortality (147) 147
health aspects (146) 146
animals (143) 143
retrospective studies (139) 139
anti-bacterial agents - administration & dosage (137) 137
infections (137) 137
risk factors (130) 130
abdomen (129) 129
aged, 80 and over (124) 124
sepsis (120) 120
peritonitis (116) 116
adolescent (111) 111
medicine & public health (109) 109
therapy (102) 102
analysis (101) 101
prospective studies (101) 101
risk-factors (100) 100
double-blind (99) 99
abridged index medicus (94) 94
care and treatment (94) 94
imipenem-cilastatin (94) 94
in-vitro activity (94) 94
klebsiella-pneumoniae (92) 92
pseudomonas-aeruginosa (91) 91
anti-bacterial agents - adverse effects (90) 90
young adult (89) 89
internal medicine (87) 87
pharmacokinetics (87) 87
research (86) 86
minocycline - analogs & derivatives (84) 84
bacteria (83) 83
drug resistance, bacterial (83) 83
drug therapy (82) 82
enterobacteriaceae (82) 82
escherichia-coli (82) 82
penicillanic acid - analogs & derivatives (82) 82
infectious disease (81) 81
peritonitis - drug therapy (81) 81
drug resistance (78) 78
epidemiology (78) 78
immunology (78) 78
critically-ill patients (77) 77
pneumonia (77) 77
skin-structure infections (75) 75
efficacy (74) 74
bacterial infections - microbiology (71) 71
child (71) 71
medicine, general & internal (71) 71
antimicrobial agents (70) 70
gastroenterology & hepatology (70) 70
tigecycline (70) 70
gram-negative bacteria (68) 68
guidelines (68) 68
drug resistance, multiple, bacterial (67) 67
hospitals (67) 67
critical care medicine (64) 64
diagnosis (64) 64
anti-bacterial agents - pharmacokinetics (63) 63
ventilator-associated pneumonia (62) 62
drug resistance in microorganisms (61) 61
safety (61) 61
septic shock (61) 61
intensive care units (60) 60
minocycline - therapeutic use (60) 60
antimicrobial resistance (59) 59
bacterial infections (59) 59
intensive-care-unit (58) 58
pediatrics (57) 57
piperacillin-tazobactam (57) 57
carbapenems (56) 56
cross infection - drug therapy (56) 56
drug therapy, combination (56) 56
gram-negative bacteria - drug effects (56) 56
peritonitis - microbiology (56) 56
rats (56) 56
resistance (56) 56
abscess (55) 55
cross infection - microbiology (55) 55
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1095) 1095
Spanish (26) 26
German (12) 12
French (10) 10
Russian (7) 7
Chinese (4) 4
Dutch (2) 2
Portuguese (2) 2
Czech (1) 1
Hungarian (1) 1
Italian (1) 1
Japanese (1) 1
Polish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 21, pp. 1996 - 2005
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 05/2015, Volume 60, Issue 10, pp. 1462 - 1471
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 754 - 762
Background. The global emergence of carbapenem-resistant Enterobacteriaceae highlights the urgent need to reduce carbapenem dependence. The phase 3 RECAPTURE... 
acute pyelonephritis | ceftazidime-avibactam | complicated urinary tract infection | INFECTIOUS DISEASES | INITIAL ANTIBIOTIC-THERAPY | ANTIMICROBIAL THERAPY | MICROBIOLOGY | IMMUNOLOGY | INTRAABDOMINAL INFECTION | CARBAPENEM-RESISTANT ENTEROBACTERIACEAE | TREATMENT OPTIONS | BACTERICIDAL ACTIVITY | PSEUDOMONAS-AERUGINOSA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | KLEBSIELLA-PNEUMONIAE | Doripenem | Azabicyclo Compounds - administration & dosage | Carbapenems - administration & dosage | Humans | Middle Aged | Male | Pyelonephritis - complications | Urinary Tract Infections - complications | Urinary Tract Infections - drug therapy | Carbapenems - adverse effects | Anti-Bacterial Agents - therapeutic use | Carbapenems - therapeutic use | Ceftazidime - administration & dosage | Adult | Azabicyclo Compounds - therapeutic use | Female | Aged | Anti-Bacterial Agents - adverse effects | Ceftazidime - adverse effects | Pyelonephritis - drug therapy | Anti-Bacterial Agents - administration & dosage | Ceftazidime - therapeutic use | Drug Combinations | Azabicyclo Compounds - adverse effects | Care and treatment | Usage | Pyelonephritis | Clinical trials | Urinary tract infections | Influence | Dosage and administration | Ceftazidime | Antibiotics | Drug resistance | Drug therapy | CRE bacteria | Urinary tract diseases | Index Medicus | and Commentaries
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2016, Volume 60, Issue 4, pp. 2443 - 2449
Nephrotoxicity is the main adverse effect of colistin and polymyxin B (PMB). It is not clear whether these two antibiotics are associated with different... 
HOSPITAL MORTALITY | ACUTE KIDNEY INJURY | GRAM-NEGATIVE BACTERIA | RISK-FACTORS | CARE MEDICAL-CENTER | POPULATION PHARMACOKINETICS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INTRAVENOUS COLISTIN | CRITICALLY-ILL PATIENTS | METHANESULFONATE | NEPHROTOXICITY | Kidney Failure, Chronic - mortality | Multivariate Analysis | Polymyxin B - administration & dosage | Body Weight | Prospective Studies | Age Factors | Humans | Middle Aged | Male | Gram-Negative Bacterial Infections - microbiology | Respiratory Tract Infections - microbiology | Respiratory Tract Infections - mortality | Kidney Failure, Chronic - pathology | Kidney Failure, Chronic - chemically induced | Aged, 80 and over | Adult | Female | Acute Kidney Injury - chemically induced | Anti-Bacterial Agents - adverse effects | Colistin - adverse effects | Respiratory Tract Infections - pathology | Intensive Care Units | Gram-Negative Bacterial Infections - pathology | Drug Administration Schedule | Acute Kidney Injury - drug therapy | Acute Kidney Injury - pathology | Colistin - analogs & derivatives | Intraabdominal Infections - microbiology | Polymyxin B - adverse effects | Kidney Failure, Chronic - drug therapy | Risk Factors | Colistin - administration & dosage | Gram-Negative Bacterial Infections - drug therapy | Respiratory Tract Infections - drug therapy | Intraabdominal Infections - mortality | Gram-Negative Bacteria - drug effects | Acute Kidney Injury - mortality | Intraabdominal Infections - pathology | Gram-Negative Bacteria - growth & development | Gram-Negative Bacteria - pathogenicity | Survival Analysis | Aged | Anti-Bacterial Agents - administration & dosage | Intraabdominal Infections - drug therapy | Gram-Negative Bacterial Infections - mortality | Index Medicus
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2013, Volume 57, Issue 7, pp. 3092 - 3099
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 12/2013, Volume 39, Issue 12, pp. 2092 - 2106
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 12/2015, Volume 61, Issue 11, pp. 1671 - 1678
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 1, pp. 268 - 272
Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 06/2012, Volume 271, Issue 6, pp. 608 - 618
Schmidt M, Horvath‐Puho E, Thomsen RW, Smeeth L, Sørensen HT (Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital,... 
infections | deep venous thrombosis | pulmonary embolism | antibacterial agents | venous thromboembolism | Pulmonary embolism | Infections | Deep venous thrombosis | Antibacterial agents | Venous thromboembolism | CONTROLLED-TRIAL | HOSPITALIZED-PATIENTS | RISK-FACTORS | LOW-DOSE HEPARIN | FATAL PULMONARY-EMBOLISM | PREVENTION | DEEP-VEIN THROMBOSIS | MEDICINE, GENERAL & INTERNAL | INFARCTION | COMMUNITY | MEDICAL PATIENTS | Prevalence | Humans | Middle Aged | Male | Pulmonary Embolism - epidemiology | Urinary Tract Infections - complications | Case-Control Studies | Cross Infection - complications | Venous Thromboembolism - drug therapy | Incidence | Outpatients - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - complications | Pulmonary Embolism - microbiology | Skin Diseases, Bacterial - complications | Female | Community-Acquired Infections - complications | Respiratory Tract Infections - complications | Odds Ratio | Venous Thromboembolism - epidemiology | Bacterial Infections - microbiology | Venous Thromboembolism - diagnosis | Acute Disease | Risk Assessment | Bacterial Infections - drug therapy | Risk Factors | Bacteremia - complications | Medical Records | Logistic Models | Inpatients - statistics & numerical data | Cross Infection - drug therapy | Pulmonary Embolism - diagnosis | Algorithms | Bacterial Infections - epidemiology | Venous Thromboembolism - microbiology | Denmark - epidemiology | Pulmonary Embolism - drug therapy | Aged | Intraabdominal Infections - complications | Index Medicus | Original
Journal Article